Completed NA INTERVENTIONAL 4-arm NCT05984186

Effect of High Velocity/Hyperoxic Breathing Therapy on Blood Lactate Decline

Wingate-type Exercise Test to Evaluate the Effect of High Velocity Therapy on Recovery Sensation and Blood Lactate Decline

Sponsor: Auburn University

Conditions Breathlessness Dyspnea Exercise Lactic Acidosis Muscle Recovery

Interventions High Velocity Therapy

Updated 4 times since 2023 Last updated: Sep 12, 2024 Started: Mar 6, 2023 Primary completion: Jul 31, 2023 Completion: Dec 31, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05984186, this NA trial focuses on Breathlessness and Dyspnea and remains completed. Sponsored by Auburn University, it has been updated 4 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Nov 2024 — Present [monthly]

Completed NA

Status: Active Not Recruiting → Completed · Phase: None → NA
Sep 2024 — Nov 2024 [monthly]

Active Not Recruiting
Jul 2024 — Sep 2024 [monthly]

Active Not Recruiting
Sep 2023 — Jul 2024 [monthly]

Active Not Recruiting

First recorded

Mar 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Auburn University
Vapotherm, Inc.

Data source: Vapotherm, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Auburn, United States